Dr. Michael Berendt reports

TELESTA THERAPEUTICS INC. ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

Telesta Therapeutics Inc. has released the voting results from its annual general meeting of shareholders held Nov. 12, 2015, in Montreal. The details of the meeting agenda and each of the agenda items can be found in the corporation's proxy circular dated Sept. 25, 2015, which can be found at SEDAR or on the corporation's website.

The five nominees for the position of director of the corporation were elected as presented in the table. Each of these individuals is to serve as a director of the corporation to hold office for the ensuing year or until his or her successor is elected.

Nominee                     Votes for     % for   Votes withheld    % withheld

Yvon Bastien              104,941,901     98.96        1,106,508          1.04
Dr. Michael Berendt       105,405,397     99.39          642,958          0.61
Lyne Fortin               105,915,181     99.87          133,228          0.13
James Rae                 104,424,859     98.85        1,618,496          1.15
Warren Whitehead          104,976,695     98.99        1,067,214          1.01     

Shareholders at the meeting also approved the reappointment of Telesta's auditor, Ernst & Young LLP, Chartered Accountants, and reapproved the group registered retirement savings and employee savings plans, the shareholders rights plan, and the 2015 amended and restated stock option plan. In addition, the advance notice bylaw of the corporation was confirmed, ratified and approved.

Finally, a special resolution amending the articles of the corporation to consolidate the issued and outstanding common shares at a ratio of up to 15 preconsolidation for every one postconsolidation common share if, as and when determined by the board of directors over a period of one year was confirmed, ratified and approved.

We seek Safe Harbor.